Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model

Weinberger, 2011, Serotype replacement in disease after pneumococcal vaccination, Lancet, 378, 1962, 10.1016/S0140-6736(10)62225-8 van Hoek, 2012, Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes, PLoS One, 7, e39150, 10.1371/journal.pone.0039150 Moffitt, 2011, Next generation pneumococcal vaccines, Curr Opin Immunol, 23, 407, 10.1016/j.coi.2011.04.002 Webster, 2011, An evaluation of emerging vaccines for childhood pneumococcal pneumonia, BMC Public Health, 11, S26, 10.1186/1471-2458-11-S3-S26 Malley, 2012, Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity, Proc Nat Acad Sci USA, 109, 3623, 10.1073/pnas.1121383109 Posfay-Barbe, 2011, Immunity to pneumococcal surface proteins in children with community-acquired pneumonia: a distinct pattern of responses to pneumococcal choline-binding protein A, Clin Microbiol Infect, 17, 1232, 10.1111/j.1469-0691.2010.03389.x Glover, 2008, Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis, Infect Immun, 76, 2767, 10.1128/IAI.01126-07 Khan, 2012, Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans, Vaccine, 30, 2900, 10.1016/j.vaccine.2012.02.023 Plumptre, 2012, Polyhistidine triad proteins of pathogenic streptococci, Trends Microbiol, 20, 485, 10.1016/j.tim.2012.06.004 Adamou, 2001, Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis, Infect Immun, 69, 949, 10.1128/IAI.69.2.949-958.2001 Beghetto, 2006, Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome lambda-display library, FEMS Microbiol Lett, 262, 14, 10.1111/j.1574-6968.2006.00360.x Ogunniyi, 2007, Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae, Infect Immun, 75, 350, 10.1128/IAI.01103-06 Melin, 2010, Interaction of pneumococcal histidine triad proteins with human complement, Infect Immun, 78, 2089, 10.1128/IAI.00811-09 Denoel, 2011, A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae, Vaccine, 29, 5495, 10.1016/j.vaccine.2011.05.051 Seiberling, 2012, Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults, Vaccine, 30, 7455, 10.1016/j.vaccine.2012.10.080 Kaur, 2011, Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children, Pediatr Infect Dis J, 30, 645, 10.1097/INF.0b013e31821c2d8b Holmlund, 2009, Antibodies to pneumococcal proteins PhtD CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage, Clin Vaccine Immunol, 16, 916, 10.1128/CVI.00050-09 Hagerman, 2012, Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemia, Clin Microbiol Infect, 18, 756, 10.1111/j.1469-0691.2011.03629.x Khan, 2012, PcpA of Streptococcus pneumoniae mediates adherence to nasopharyngeal and lung epithelial cells and elicits functional antibodies in humans, Microbes Infect/Institut Pasteur, 14, 1102, 10.1016/j.micinf.2012.06.007 Briles, 2003, Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae, J Infect Dis, 188, 339, 10.1086/376571 Tai, 2006, Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies, Crit Rev Microbiol, 32, 139, 10.1080/10408410600822942 Salha, 2012, Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury, Infect Immun, 80, 2212, 10.1128/IAI.06348-11 Kirkham, 2006, Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines, Infect Immun, 74, 586, 10.1128/IAI.74.1.586-593.2006 Ogunniyi, 2001, Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA, Infect Immun, 69, 5997, 10.1128/IAI.69.10.5997-6003.2001 Kamtchoua, 2013, Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults, Vaccine, 31, 327, 10.1016/j.vaccine.2012.11.005 Hinojosa, 2009, Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia, J Infect Dis, 200, 546, 10.1086/600870 Ljutic, 2012, Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants, Vaccine, 30, 2981, 10.1016/j.vaccine.2012.02.038 Oloo, 2011, Structure-guided antigen engineering yields pneumolysin mutants suitable for vaccination against pneumococcal disease, J Biol Chem, 286, 12133, 10.1074/jbc.M110.191148 Johnston, 2006, Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence, Infect Immun, 74, 1171, 10.1128/IAI.74.2.1171-1180.2006 Bernatoniene, 2005, Advances in pneumococcal vaccines: advantages for infants and children, Drugs, 65, 229, 10.2165/00003495-200565020-00005 Shaper, 2004, PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected], Infect Immun, 72, 5031, 10.1128/IAI.72.9.5031-5040.2004 Garcia-Suarez Mdel, 2004, Protection against pneumococcal pneumonia in mice by monoclonal antibodies to, pneumolysin, Infect Immun, 72, 4534, 10.1128/IAI.72.8.4534-4540.2004 Musher, 2001, Protection against bacteremic pneumococcal infection by antibody to pneumolysin, J Infect Dis, 183, 827, 10.1086/318833